Review Shows Little Risk for Myocarditis in COVID-19
Myocarditis has an ‘extremely low frequency’ in the setting of COVID-19 and biopsy is not recommended, concludes a review of published cases to date.
Myocarditis has an ‘extremely low frequency’ in the setting of COVID-19 and biopsy is not recommended, concludes a review of published cases to date.
Alison Bailey, MD, co-chair of the business of cardiology sessions at ACC.24, emphasized that reimbursement cuts can have a long-term negative impact on patient.
WASHINGTON (April 25, 2024) – Efforts by the American College of Cardiology, the American Heart Association, the Heart Failure Society of America, the Heart Rhythm…
Low delta entropy on EEG was able to better predict outcomes than traditional overnight polysomnography measures.
Nonprescription rosuvastatin pans out in a second trial
After ORBITA-COSMIC, Reducer device’s mechanism of benefit remains unknown
Randomized trial shows better outcomes for patients with acute coronary syndromes
Patient acceptance could be an advantage, researchers say
IVUS-DCB is now the second trial to support intravascular imaging in peripheral interventions—what will it take to increase its use?
Patients went home with self-testing devices plus remote access to a cardiologist—readmissions, events, and symptoms improved.
Contact: Nicole Napoli , nnapoli@acc.org, 202-669-1465 People who have had a heart attack or who are at risk for a heart attack and who stopped…